Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 52 in last 24h · 115,243 total before filter · latest 1h ago
52last 24h
1809last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings856M&A105Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Pfizer (PFE) Stock Looks Reasonable On Returns But Stretched On Earnings
Simply Wall St.16h agoneutral
Pfizer (PFE) Stock Looks Reasonable On Returns But Stretched On Earnings

Pfizer stock has delivered a roughly 28% decline over the past five years, yet recent gains and a mixed set of valuation checks mean the current price is not an obvious bargain or clear bubble. With fresh product news and shifting expectations around its portfolio, investors are weighing whether the recent rebound leaves enough room for attractive long term returns. The share price is down about 28% over five years. This points to a company that has yet to fully reward long term holders...

The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call
StockStory16h agoneutral
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

Halozyme Therapeutics delivered a notably positive second quarter, as evidenced by the strong market reaction and management’s attribution of outperformance to surging royalty revenue and a wave of new collaboration agreements. CEO Helen Torley highlighted that the ENHANZE platform, now underpinning revenue from six different drugs, enabled a record 50% year-over-year royalty growth. The quarter also benefited from sizable milestone payments tied to newly signed licensing deals, with Torley emph

5 Must-Read Analyst Questions From Fiserv’s Q2 Earnings Call
StockStory17h agoneutral
5 Must-Read Analyst Questions From Fiserv’s Q2 Earnings Call

Fiserv’s second quarter saw a negative market reaction, as management highlighted several reasons for the company’s performance. CEO Takis Georgakopoulos pointed to persistent macroeconomic headwinds in Argentina and slower client implementation timelines as primary factors weighing on near-term revenue. Additional pressure came from a weaker hardware sales environment and a flattening of small business volumes. Georgakopoulos acknowledged the company’s need to accelerate operational improvement

Amkor (AMKR) Stock Looks Cheap On Cash Flow But Less So On Earnings
Simply Wall St.18h agoneutral
Amkor (AMKR) Stock Looks Cheap On Cash Flow But Less So On Earnings

Amkor Technology stock has delivered strong long term returns over the past five years, yet current checks suggest the market price may still sit below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples. Amkor Technology has returned 153.7% over five years, which puts the recent pullback into context for longer term holders. The expanded advanced packaging work with partners such as Nvidia can support expectations for future cash flows. At...

The 5 Most Interesting Analyst Questions From ATI’s Q2 Earnings Call
StockStory19h agoneutral
The 5 Most Interesting Analyst Questions From ATI’s Q2 Earnings Call

ATI’s second quarter results were well received by the market, following strong year-on-year growth driven by the company’s ongoing portfolio transformation and higher-value product mix. Management attributed the quarter’s performance to operational improvements, a record backlog, and robust demand in aerospace and defense segments. CEO Kimberly Fields highlighted the transformation of the AA&S segment, stating, “What was once viewed as a more cyclical, lower-margin business has become a second

Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance?
Simply Wall St.19h agobullish
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance?

In the June quarter, Boston Scientific completed a share repurchase of 39,922,436 shares, equal to 2.69% of its stock, for US$2,000.11 million under the buyback first announced in December 2020, while quarterly results highlighted underperformance in U.S. Electrophysiology and Watchman alongside lower 2026 organic sales growth guidance. Although the CHAMPION-AF trial met all clinical endpoints, it did not act as a meaningful catalyst for the business outlook, and the contrast between bullish...

5 Revealing Analyst Questions From nLIGHT’s Q2 Earnings Call
StockStory19h agoneutral
5 Revealing Analyst Questions From nLIGHT’s Q2 Earnings Call

nLIGHT’s second quarter saw strong revenue growth, surpassing Wall Street’s expectations, but the market reacted negatively due to concerns over future earnings and supply chain disruptions. Management attributed the robust sales to increased demand in both defense and advanced manufacturing, with significant contributions from new directed energy contracts and a growing pipeline in laser sensing applications. CEO Scott Keeney highlighted the importance of recent defense awards and record revenu

5 Insightful Analyst Questions From Howmet’s Q2 Earnings Call
StockStory20h agoneutral
5 Insightful Analyst Questions From Howmet’s Q2 Earnings Call

Howmet’s second quarter was marked by broad-based growth across its end markets, with management highlighting strong demand from both commercial and defense aerospace customers as well as the industrial gas turbine segment. The company’s leadership attributed the performance to increased aircraft build rates, elevated spares activity, and a recovery in commercial transportation. CEO John Plant emphasized that organic growth remained robust even after accounting for recent acquisitions, with spar

The Top 5 Analyst Questions From Datadog’s Q2 Earnings Call
StockStory21h agoneutral
The Top 5 Analyst Questions From Datadog’s Q2 Earnings Call

Datadog’s Q2 results were met with a significant negative market reaction, despite the company delivering revenue and non-GAAP profit above Wall Street’s expectations. Leadership pointed to continued acceleration in both AI-native and traditional customer segments, as well as broad product adoption, as the main drivers of quarterly performance. CEO Olivier Pomel noted, “We continue to see healthy trends in customer demand,” emphasizing that the platform’s usage is expanding across a wide range o

Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings?
StockStory22h agoneutral
Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings?

Since August 2021, the S&P 500 has delivered a total return of 73.7%. But one standout stock has more than doubled the market - over the past five years, Covenant Logistics has surged 201% to $33.37 per share. Its momentum hasn’t stopped as it’s also gained 18.8% in the last six months, beating the S&P by 5.4%.

Jim Cramer Weighs In on Lumentum (LITE) and Coherent (COHR) Post-Earnings
Insider Monkey22h agoneutral
Jim Cramer Weighs In on Lumentum (LITE) and Coherent (COHR) Post-Earnings

Shares of optical technology leaders Lumentum Holdings Inc. (NASDAQ:LITE) and Coherent Corp. (NYSE:COHR) experienced some action after the quarterly reports. During the August 12 episode of CNBC’s Mad Money, Jim Cramer highlighted the short-term disconnect between market trading dynamics and business fundamentals in the optical hardware space. He noted: Sometimes, even the best stocks get […]

JFrog (FROG) Is Up 7.4% After Raising Guidance On AI-Fueled Cloud Security Demand - Has The Bull Case Changed?
Simply Wall St.23h agoneutral
JFrog (FROG) Is Up 7.4% After Raising Guidance On AI-Fueled Cloud Security Demand - Has The Bull Case Changed?

In August 2026, JFrog reported Q2 results showing revenue rising to US$163.77 million with a sharply smaller net loss, while also issuing higher full-year revenue guidance and highlighting accelerating demand for its cloud and security offerings amid AI-driven software development. JFrog’s upcoming swampUP 2026 conference in New York, featuring security and AI leaders from Anthropic, Microsoft, NVIDIA and others, underlines its push to position the platform at the center of securing AI-era...

Taiwan Semiconductor Manufacturing (TSM) Stock Trades Rich On Cash Flow While Earnings Look Cheaper
Simply Wall St.23h agoneutral
Taiwan Semiconductor Manufacturing (TSM) Stock Trades Rich On Cash Flow While Earnings Look Cheaper

Taiwan Semiconductor Manufacturing stock has rallied hard over the past few years, yet its current price screens as expensive on a Discounted Cash Flow (DCF) intrinsic value estimate while earnings based multiples still suggest room for optimism. That split has put valuation in sharp focus after a strong run in the share price. Over the last 3 years, Taiwan Semiconductor Manufacturing has delivered a very large total return of about 3.8x, which puts extra scrutiny on whether today’s price...

nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?
StockStory1d agoneutral
nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?

nCino has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $19.16, marking a 20.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Arista Networks (ANET) Is Up 5.9% After AI-Fueled Q3 Revenue Guidance Upgrade - Has The Bull Case Changed?
Simply Wall St.1d agobullish
Arista Networks (ANET) Is Up 5.9% After AI-Fueled Q3 Revenue Guidance Upgrade - Has The Bull Case Changed?

In the past week, Arista Networks reported second-quarter 2026 results showing revenue of US$3.04 billion and net income of US$1.21 billion, alongside guidance for roughly US$3.30 billion in third-quarter revenue. Management linked this stronger outlook to accelerating demand for AI-driven network deployments, underscoring how AI data center spending is increasingly central to Arista’s growth story. We’ll now examine how this AI-fueled guidance upgrade might reshape Arista Networks’...